MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks
- 1 May 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 355 (9217), 1818-1821
- https://doi.org/10.1016/s0140-6736(00)02276-5
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal RecoveryJournal of Neuroscience, 1999
- Ecstasy use in Australia: patterns of use and associated harmDrug and Alcohol Dependence, 1999
- 3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humansNeuroscience & Biobehavioral Reviews, 1999
- Studies on the role of dopamine in the degeneration of 5‐HT nerve endings in the brain of Dark Agouti rats following 3,4‐methylenedioxymethamphetamine (MDMA or ‘ecstasy’) administrationBritish Journal of Pharmacology, 1999
- Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dancePsychopharmacology, 1998
- In vivo detection of short- and long-term MDMA neurotoxicity?a positron emission tomography study in the living baboon brainSynapse, 1998
- Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")Journal of Neuroscience, 1995
- Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drugBritish Journal of Addiction, 1992
- Extrapolation of Toxicological and Pharmacological Data from Animals to HumansPublished by Elsevier ,1991
- Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administrationBrain Research, 1988